Varex/$VREX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Varex

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Ticker

$VREX
Primary listing

Industry

Health Care Equipment & Supplies

Employees

2,300

ISIN

US92214X1063

Varex Metrics

BasicAdvanced
$343M
-
-$1.02
0.62
-

What the Analysts think about Varex

Analyst ratings (Buy, Hold, Sell) for Varex stock.

Bulls say / Bears say

B.Riley initiated coverage on Varex Imaging with a Buy rating and a price target of $21.00, citing the company's expertise in creating highly complex components as a competitive advantage. (Investing.com)
Varex Imaging received orders valued at approximately $14 million for its new high-energy cargo inspection systems, indicating a growing need for advanced security solutions globally. (Investing.com)
The company's balance sheet showed a healthy cash flow from operations at $10 million for the quarter, with cash, cash equivalents, and marketable securities totaling $219 million at the end of the first quarter. (Investing.com)
Jefferies analyst Matthew Taylor adjusted Varex Imaging's price target to $15.00 from $16.00, maintaining a Hold rating, following a 20% stock drop after first-quarter results. (Investing.com)
Varex Imaging's first-quarter revenue of $199.8 million represented a 5.2% year-over-year increase but fell short of the Zacks Consensus Estimate of $204.55 million. (Nasdaq)
Dimensional Fund Advisors LP decreased its position in Varex Imaging by 4.1% in the fourth quarter, selling 91,183 shares during the period. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 11 Jun 2025.

Varex Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Varex Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VREX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs